Fate Therapeutics Inc (FATE) Becoming More Attractive for Investors
In a filing, Fate Therapeutics Inc revealed its Chief Financial Officer Dulac Edward J III unloaded Company’s shares for reported $19013.0 on Mar 04 ’24. In the deal valued at $7.77 per share,2,447 shares were sold. As a result of this transaction, Dulac Edward J III now holds 101,479 shares worth roughly $0.55 million. Then, […]
FATE (Fate Therapeutics Inc) may reap gains as insiders became active recently
Fate Therapeutics Inc’s filing revealed that its Chief Financial Officer Dulac Edward J III unloaded Company’s shares for reported $19013.0 on Mar 04 ’24. In the deal valued at $7.77 per share,2,447 shares were sold. As a result of this transaction, Dulac Edward J III now holds 101,479 shares worth roughly $0.69 million. Then, Dulac […]
Insider Sale Alert: Fate Therapeutics Inc [FATE] – Is it Time to sell?
In a filing, Fate Therapeutics Inc revealed its Chief Financial Officer Dulac Edward J III unloaded Company’s shares for reported $19013.0 on Mar 04 ’24. In the deal valued at $7.77 per share,2,447 shares were sold. As a result of this transaction, Dulac Edward J III now holds 101,479 shares worth roughly $0.69 million. Then, […]
Fate Therapeutics Inc (FATE) may enjoy gains as insiders got busy in the recent days
In a filing, Fate Therapeutics Inc revealed its Chief Financial Officer Dulac Edward J III unloaded Company’s shares for reported $19013.0 on Mar 04 ’24. In the deal valued at $7.77 per share,2,447 shares were sold. As a result of this transaction, Dulac Edward J III now holds 101,479 shares worth roughly $0.7 million. Then, […]
